BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2020
A multicenter, randomized, double-blind, active-controlled, phase III clinical trial to evaluate the efficacy and safety of BPDO-1603 in patients with moderate-to-severe Alzheimer\'s disease
Epistemonikos ID: 3428963e9984bce74e34f4dc56e57415b4958651
First added on: Dec 20, 2022